5 mg/mL, irregular heart rate or heart rate > 100 beats per minute). Also, hyperacute stroke patients eligible for reperfusion therapy were not considered for this study until their neurologists confirmed that they could be approached for consent without delaying treatment. Erismodegib clinical trial Our institutional review board approved this study and informed consent was obtained for each patient. CT studies were performed on a 64-slice multidetector CT scanner (“Lightspeed VCT,” General Electric)

without prior administration of beta-blockers or nitroglycerin. A combined carotid-coronary CT angiography (CTA) series was obtained and consisted of two helical acquisitions and a dual phase contrast injection (Supp Fig 1). The first acquisition was non-ECG-gated,

ascending from http://www.selleckchem.com/products/Gefitinib.html the aortic arch to the vertex of the head. The second acquisition was performed during a breath-hold and was retrospectively ECG-gated, descending from the aortic arch to the diaphragm. The acquisition parameters were as follows: 64 mm × .625 mm collimation, 0.33-second gantry rotation-time, 120 kV tube voltage, and 850 mA tube current. A slice-thickness of 1.25 mm and a pitch of .92 were used for the aortic arch, carotid, and intracranial arteries, whereas a slice-thickness of .625 mm and a pitch of .2 were used for the coronary arteries. The time to maximal enhancement on bolus testing was used to calculate the contrast transit time. This transit time determined the delay between the initial contrast injection and the first acquisition. The dual phase contrast injection consisted

of two boluses of 30 cc and 60 cc iodinated contrast material (iohexol, Omnipaque, Amersham Health, Princeton, NJ, USA; 350 mg/mL of iodine) injected into the right or left (preferably the right) cubital vein, followed by saline injection phases of 15 cc and 60 cc, respectively. The injection rate was 5 cc/second for both the contrast and the saline. Radiation dose associated with our CTA protocol was exactly 上海皓元 the same as for a regular neck CTA protocol, with an effective dose in the order of 3–4 mSv. The CTA studies were exported to an off-line PC computer and were processed automatically using a custom, automated classifier computer algorithm. This computer algorithm was developed using Matlab-based software (The MathWorks, Inc., Novi, MI, USA) and was validated using histology derived from carotid endarterectomy specimens as gold standard.[20] The algorithm automatically segments the inner and outer contours of the carotid artery wall and distinguishes among its histological components (lipid, calcium, fibrous tissue) using appropriate thresholds of CT density.[20] It then creates a color overlay that visually displays the composition of the carotid artery wall for each CTA image slice (Supp Fig 2).